Exfoliative dermatitis - Dermatitis Exfoliative
☆ AI Dermatology — Free Service
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
Red (burning) Skin Syndrome ― Erythema me te unahi ki te tinana katoa, ko ngā tohu matua o Dermatitis Exfoliative (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesKo te Erythroderma he mate kiri onge, engari he kino. Ahakoa kāore i te mōhiotia te take tika, ka puta mai i te hohenga tarukino, i te mate pūkūpuku o raro rānei. He pūkūpuku kotahi anake e hono ana ki te dermatitis exfoliative, ko te T‑cell lymphoma, ā, kāore pea e whakaatu tohu mō ngā marama, ngā tau rānei i muri i te tīmata o te mate kiri. I te nuinga o te wā, ka hiahiatia te hohipera mō te aromatawai tuatahi me te maimoatanga. Ko ngā turoro e mau ana i te mate nā roto i te tarukino he pai mō te tirohanga wā roa, ahakoa kāore he take mārama i ngā kīhē, ka hoki mai anō, ka tukuna. Ko te tohu mō ngā kīhē e hono ana ki te pūkūpuku ka whakawhirinaki ki te āhua o te ahunga whakamua o te pūkūpuku.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
I te nuinga o te wā ka kitea te whero me te pahekeheke e hipoki ana i te 90% o te tinana. Ko tēnei ahuatanga he tohu kitea o ngā momo take hauora kei raro pērā i te psoriasis, eczema, he urupare rānei ki ētahi rongoā.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Ko te take nui o te erythroderma ko te whakaparahako o te mate kiri o raro, pērā i te psoriasis, te contact dermatitis, te seborrheic dermatitis, te lichen planus, te pityriasis rubra pilaris, te tauhohenga tarukino, me te whakamahi i ngā steroids. He iti ake te paheketanga tuatahi, ka kitea i te nuinga o ngā wā o te lymphoma kiri T‑cell. Nō te mea he mea nui ki te wehewehe i te lymphoma pūtau T‑kiri, ka mahia he koiora.